Pacira BioSciences Reiterates Full-year 2024 Financial Guidance Total Revenue Of $680M - $705M, Est $694.66M
Portfolio Pulse from Benzinga Newsdesk
Pacira BioSciences has reiterated its full-year 2024 financial guidance, projecting total revenue between $680 million and $705 million, aligning closely with the estimated $694.66 million.
July 30, 2024 | 8:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Pacira BioSciences has reiterated its full-year 2024 financial guidance, projecting total revenue between $680 million and $705 million, which aligns closely with the estimated $694.66 million.
The reaffirmation of financial guidance within the expected range is likely to instill confidence among investors, potentially leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100